We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$20.9B
AUM Growth
+$3.23B
(+18%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
19.82%
Holding
593
New
94
Increased
215
Reduced
210
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NOV
NOV
|
+$121M |
| 2 |
NetEase
NTES
|
+$98.7M |
| 3 |
Viatris
VTRS
|
+$94.3M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$85.7M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$85.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$146M |
| 2 |
Meta Platforms (Facebook)
META
|
+$85.3M |
| 3 |
Microsoft
MSFT
|
+$78.2M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$68.7M |
| 5 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.59% |
| 2 | Technology | 13.29% |
| 3 | Financials | 11.96% |
| 4 | Communication Services | 10.26% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Mastercard
MA
$487B
| $14.7M | 0.07% |
219,170
-170,950
| -44% | -$10.7M |
|
252
Canadian Pacific Kansas City
CP
$81.1B
| $14.7M | 0.07% |
597,255
-162,300
| -21% | -$4.01M |
|
|
CYOU
253
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $14.7M | 0.07% |
412,500
-436,021
| -51% | -$14M |
|
254
Western Digital
WDC
$172B
| $14.6M | 0.07% |
304,290
| – | – |
|
|
PLG
255
Platinum Group Metals
PLG
$162M
| $14.6M | 0.07% |
144,363
+2,064
| +1% | +$214K |
|
256
FMC
FMC
$1.39B
| $14.5M | 0.07% |
232,943
+54,183
| +30% | +$3.11M |
|
257
Estee Lauder
EL
$30.1B
| $14.4M | 0.07% |
206,535
-219,941
| -52% | -$14.9M |
|
258
American Express
AXP
$229B
| $14.3M | 0.07% |
189,308
-3,112
| -2% | -$234K |
|
259
Lam Research
LRCX
$365B
| $14M | 0.07% |
2,733,320
+616,480
| +29% | +$3.01M |
|
260
UnitedHealth
UNH
$379B
| $13.8M | 0.07% |
193,007
-107,840
| -36% | -$7.72M |
|
261
Albemarle
ALB
$13.7B
| $13.7M | 0.07% |
217,170
+28,520
| +15% | +$1.8M |
|
262
Teva Pharmaceuticals
TEVA
$36.2B
| $13.6M | 0.07% |
359,800
+17,100
| +5% | +$667K |
|
|
DANG
263
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| $13.5M | 0.06% |
+1,292,275
| New | +$11.4M |
|
264
Equity Residential
EQR
$25.2B
| $13.3M | 0.06% |
+247,535
| New | +$13.6M |
|
265
Biogen
BIIB
$29.5B
| $13.2M | 0.06% |
54,888
+15,400
| +39% | +$3.45M |
|
|
SWY
266
DELISTED
SAFEWAY INC
SWY
| $13.1M | 0.06% |
457,327
-58,737
| -11% | -$1.4M |
|
267
Emerson Electric
EMR
$83.6B
| $13M | 0.06% |
200,348
-269,100
| -57% | -$16.5M |
|
268
Allstate
ALL
$67.3B
| $12.9M | 0.06% |
255,400
-49,100
| -16% | -$2.47M |
|
269
Target
TGT
$63.7B
| $12.9M | 0.06% |
201,595
-117,251
| -37% | -$7.98M |
|
270
Barclays
BCS
$96.3B
| $12.9M | 0.06% |
816,367
-6,733
| -0.8% | -$105K |
|
271
Verisk Analytics
VRSK
$27.1B
| $12.7M | 0.06% |
194,889
-3,067
| -2% | -$193K |
|
272
SL Green Realty
SLG
$3.83B
| $12.6M | 0.06% |
+146,452
| New | +$12.8M |
|
|
MANT
273
DELISTED
Mantech International Corp
MANT
| $12.4M | 0.06% |
+432,573
| New | +$12.2M |
|
|
SPRD
274
DELISTED
SPREADTRUM COMMUNICATIONS INC ADS (CAYMAN ISLANDS)
SPRD
| $12.4M | 0.06% |
407,723
-1,617,471
| -80% | -$47.9M |
|
|
WOOF
275
DELISTED
VCA Inc.
WOOF
| $12.3M | 0.06% |
449,030
+75,331
| +20% | +$2.11M |
|
Similar funds
Fidelity International's Q3 2013 Portfolio in Review
As of Q3 2013, Fidelity International held 593 positions worth $20.9B, up 18% from $17.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fidelity International deployed $1.55B of net new capital in Q3 2013, opening 94 new positions and adding to 215 existing holdings. Its largest new stake was Viatris: 2,677,695 shares worth $102M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $146M trimmed.
- Fidelity International's largest Q3 2013 buy was Viatris: 2,677,695 shares worth $102M.
- Fidelity International added most to NOV in Q3 2013, an estimated $121M increase.
- Fidelity International's biggest Q3 2013 reduction was Pfizer, cutting an estimated $146M.
- Fidelity International fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $58.5M.
- Fidelity International's ten largest holdings make up 20% of its $20.9B portfolio in Q3 2013.
- Fidelity International opened 94 new positions and closed 50 in Q3 2013.
- Fidelity International's portfolio value rose 18% quarter-over-quarter to $20.9B.
Based on Fidelity International's 13F filing for Q3 2013, filed 14 Nov 2013.